CAH vs MRK · P/E 35, rev $254.25B vs P/E 33, rev $16.61B
Cardinal Health Inc (CAH) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the CAH and MRK stock pages for the full models.
Not investment advice.